U.S. Media Stock News

NYSE:LNC
NYSE:LNCInsurance

How Six Straight Quarters of Income Growth Could Shape Lincoln National’s (LNC) Capital Return Path

In early March 2026, Lincoln National reported its sixth consecutive quarter of growth in adjusted operating income, with management highlighting broad-based strength across Group Protection, Annuities, Retirement Plan Services, and Life Insurance on its Q4 2025 earnings call. At the same time, analysts at firms such as Wells Fargo and Morgan Stanley reiterated positive views on the insurer, emphasizing improving free cash flow, lower leverage, and clearer prospects for future capital...
NYSE:WLY
NYSE:WLYMedia

John Wiley & Sons (WLY) Is Up 20.8% After Return To Profitability And New AI Content Deal – Has The Bull Case Changed?

In early March 2026, John Wiley & Sons, Inc. reported fiscal third-quarter sales of US$410.04 million, returning to a net income of US$29.68 million and positive earnings per share from continuing operations after a loss in the same period a year earlier. Separately, OpenEvidence announced a partnership to integrate a wide portfolio of Wiley’s peer-reviewed medical and scientific content into its point-of-care platform, highlighting how Wiley’s research assets are being embedded in...
NYSE:LII
NYSE:LIIBuilding

Lennox Enters Water Heating With Ariston JV As Valuation Stays Steady

Lennox International (NYSE:LII) has entered the North American water heating market through a joint venture with Ariston Group. The partnership is launching a new line of water heaters, adding to Lennox's existing product portfolio. The move expands Lennox's dealer network and allows contractors to offer integrated HVAC and water heating solutions. Lennox International, best known for residential and commercial HVAC systems, is now stepping into water heating, a closely related category...
NYSE:THC
NYSE:THCHealthcare

Has The Surge In Tenet Healthcare (THC) Shares Left Much Upside On The Table?

If you are wondering whether Tenet Healthcare at around US$236.95 is still offering value after a strong run, or if most of the upside is already priced in, this article is here to help you frame that question clearly. The stock has been volatile recently, with a 1% decline over the last 7 days, a 24.3% gain over the last 30 days, an 18.8% return year to date, an 85.9% return over 1 year, and a very large 3 year and 5 year return. This naturally raises questions about risk, sentiment, and...
NasdaqGS:OMDA
NasdaqGS:OMDAHealthcare

Omada Health (OMDA) Is Up 14.4% After GLP-1 Flex Launch and Narrowed 2025 Net Loss

In early March 2026, Omada Health launched its GLP-1 Flex Care program for employer clients and reported fourth-quarter 2025 revenue of US$75.85 million with net income of US$5.16 million, alongside full-year 2025 revenue of US$260.21 million and reduced annual net loss of US$12.78 million. By combining a cash-pay GLP-1 access model that limits employers’ drug spend with improving profitability metrics, Omada is positioning its virtual care platform as both a cost-control and...
NYSE:TPB
NYSE:TPBTobacco

Institutional Split On Turning Point Brands Nicotine Pouch Pivot And Valuation

Large investors have been actively reshaping their positions in Turning Point Brands (NYSE:TPB) following the company’s move toward nicotine pouches. Apis Capital Advisors has raised its stake, while Cannell Capital has cut its holdings, with both changes occurring soon after a strong earnings report. These moves highlight differing views on the shift from legacy products to modern oral nicotine and the role of nicotine pouches in TPB’s future. Turning Point Brands, trading at $91.66, has...
NYSE:IEX
NYSE:IEXMachinery

Assessing IDEX (IEX) Valuation After Recent Share Price Cooling And Cost-Saving Plans

IDEX (IEX) has drawn investor attention after recent share price moves, with the stock showing mixed returns over the past month and past 3 months, prompting a closer look at its current valuation setup. See our latest analysis for IDEX. At around $197.90, IDEX’s recent 1 day and 7 day share price declines of 2.67% and 5.52% sit against a 90 day share price return of 11.47% and year to date share price return of 10.52%. Longer multi year total shareholder returns have been more muted, which...
NasdaqGS:GFS
NasdaqGS:GFSSemiconductor

GlobalFoundries Renesas Deal Deepens Auto Chip Focus And Supply Security

GlobalFoundries (NasdaqGS:GFS) announced a multi billion dollar manufacturing partnership with Renesas Electronics. The agreement focuses on supplying automotive grade chips, particularly microcontrollers used across vehicles. Production is set to begin in the US, with plans for future capacity expansion in other regions. The partnership is framed as a way to support supply chain security for critical automotive semiconductors. For GlobalFoundries, this deal sits at the intersection of its...
NYSE:ARES
NYSE:ARESCapital Markets

Does Ares’s Shelf Filing and Unitranche Deal Reframe the Bull Case for Ares Management (ARES)?

In late February, Ares Management filed an omnibus shelf registration covering Class A common stock, preferred stock, debt securities, depositary shares, warrants, purchase contracts, and units, while also participating in a multi‑billion‑dollar unitranche financing backing Thoma Bravo’s acquisition and merger of WWEX Group and Auctane. These developments came as Ares faced increased scrutiny over private credit risks and an earnings miss, highlighting the tension between its expanding...
NYSE:CI
NYSE:CIHealthcare

A Look At Cigna Group’s (CI) Valuation As Recent Share Weakness Tests The Specialty Growth Story

How Cigna Group’s Recent Performance Sets Up the Valuation Debate Cigna Group (CI) has drawn investor attention after recent share performance that includes a 3.4% one day decline and a 6.3% drop over the past week, sharpening focus on its current valuation and fundamentals. See our latest analysis for Cigna Group. The recent 1 day share price decline and weak 7 day share price return compare with a year to date share price decline of 2.7% and a 1 year total shareholder return decline of...
NasdaqGS:IONS
NasdaqGS:IONSBiotechs

Ionis Pharmaceuticals (IONS) Valuation Check As FDA Grants Priority Review For Olezarsen

Ionis Pharmaceuticals (IONS) is back in focus after the US FDA accepted a Priority Review for its supplemental New Drug Application for olezarsen in severe hypertriglyceridemia, placing a key RNA medicine under a tighter regulatory timeline. See our latest analysis for Ionis Pharmaceuticals. Despite the latest FDA Priority Review, Ionis Pharmaceuticals' recent share price momentum has cooled, with a 30 day share price return of 12.88% and a year to date share price return decline of 7.07%,...
NasdaqGM:SYM
NasdaqGM:SYMMachinery

Assessing Symbotic (SYM) Valuation After Strong Fiscal Q1 Growth And Expanded Warehouse Deployments

What Symbotic’s latest quarter means for investors Symbotic (SYM) reported a fiscal Q1 that featured revenue near US$630 million and margin expansion as more warehouse automation sites moved into steady operations, drawing fresh attention to the stock. See our latest analysis for Symbotic. Despite a stronger fiscal Q1 narrative, Symbotic’s recent share price has been under pressure, with a 1-day share price return of an 8.63% decline and a year-to-date share price return of a 25.07% decline...
NasdaqGS:STLD
NasdaqGS:STLDMetals and Mining

Assessing Steel Dynamics (STLD) Valuation After Recent Share Price Pullback And Long Term Gains

With no single headline driving Steel Dynamics (STLD) today, investors are instead weighing its recent performance, including a past 3 months return near 10% and a 1 year total return around 47%. See our latest analysis for Steel Dynamics. At a share price of US$181.61, Steel Dynamics has recently seen a 1 month share price return of about a 9% decline, even though its 1 year total shareholder return is around 47%. This suggests that shorter term momentum looks softer than the longer term...
NasdaqGM:ARDX
NasdaqGM:ARDXBiotechs

Is Ardelyx (ARDX) Pricing Reflect Its DCF Upside After Recent Share Price Volatility

If you are asking yourself whether Ardelyx at around US$6.19 is attractively priced or not, this article is going to walk through what the current market price might be implying about its value. The share price has seen mixed returns, including a 5.5% decline over the last week and a 16.1% decline over the last month, alongside a 16.8% return over the past year and 73.9% over three years. Year to date performance is around 0.7%, and the 5 year return reflects an 11.2% decline. Recent trading...
NasdaqGS:BIIB
NasdaqGS:BIIBBiotechs

Biogen’s Dravet And SMA Advances Add Depth To Long Term Story

Biogen (NasdaqGS:BIIB) and Stoke Therapeutics reported promising clinical results for zorevunersen in Dravet syndrome, with data highlighting durable seizure reductions and cognitive benefits. The zorevunersen findings were published in The New England Journal of Medicine, supporting its potential as a disease modifying therapy for this rare, severe epilepsy. Biogen released new high dose SPINRAZA data for spinal muscular atrophy, including long term safety and efficacy updates. The company...
NasdaqGS:MKTX
NasdaqGS:MKTXCapital Markets

Is It Time To Reassess MarketAxess (MKTX) After Recent Share Price Volatility?

If you are wondering whether MarketAxess Holdings at around US$186 still reflects its underlying value, this article walks through the key numbers that matter. The stock has had a mixed run, with a 14.6% return over the last 30 days and a 4.2% gain year to date, set against a 9.5% decline over 1 year and deeper falls of 44.1% over 3 years and 62.0% over 5 years. These moves have kept MarketAxess on the radar for investors who follow how electronic bond trading platforms are priced and used,...
NasdaqGM:GDS
NasdaqGM:GDSIT

Is It Too Late To Reassess GDS Holdings (GDS) After Its Recent Share Price Recovery?

If you are wondering whether GDS Holdings is priced attractively today or if the recent share moves have already priced in the story, this article walks through what the numbers are really saying about its valuation. The stock last closed at US$40.87, with a 12.4% return over the past year, a 6.6% gain year to date, and longer term results that include a very large 3 year return alongside a 55.2% decline over 5 years, which can change how investors view both its potential and its...
NasdaqGM:USAR
NasdaqGM:USARMetals and Mining

USA Rare Earth Gains Full Round Top Control In Mine To Magnets Push

USA Rare Earth (NasdaqGM:USAR) is acquiring all outstanding shares of Texas Mineral Resources. The deal consolidates 100% ownership and control of the Round Top Project in Texas. Round Top is described as one of the largest rare earth deposits in North America. Completion of the transaction makes USA Rare Earth the sole operator and economic beneficiary of the project. For you as an investor, this move places a key U.S. rare earth asset fully under NasdaqGM:USAR, aligning ownership,...
NasdaqGM:WLFC
NasdaqGM:WLFCTrade Distributors

Assessing Willis Lease Finance (WLFC) Valuation After Asia Pacific Hire And Dash 8 400 Leaseback Expansion

Willis Lease Finance (WLFC) just paired two expansion themed moves by naming aviation finance veteran Marilyn Gan as Head of Origination, Asia Pacific and completing a six aircraft Dash 8 400 purchase and leaseback with Porter Airlines. See our latest analysis for Willis Lease Finance. Those moves come after a sharp pullback, with a 7 day share price return of 12.32% and a 1 day dip of 3.82%. Over a 90 day period the share price return is 36.31%, and the 3 year total shareholder return is...
NasdaqGS:REG
NasdaqGS:REGRetail REITs

Assessing Regency Centers (REG) Valuation After Recent Share Price Momentum

Regency Centers overview and recent share performance Regency Centers (REG) has attracted fresh attention among income focused investors. The real estate investment trust operates grocery anchored shopping centers, is included in the S&P 500, and recently traded at a share price of $78.66. Over the past month the stock shows a 5.9% return, with around 14.5% over the past 3 months and about 15.7% year to date, while the 1 year total return stands near 10.7%. See our latest analysis for Regency...
NasdaqGS:PSKY
NasdaqGS:PSKYMedia

Paramount Skydance’s Mega Warner Bros. Deal Reshapes Value And Risk Profile

Paramount Skydance (NasdaqGS:PSKY) has secured board approval from Warner Bros. Discovery for a "Superior Proposal" acquisition. The deal combines Paramount Skydance with Warner Bros. Discovery’s film, TV, and streaming assets in what is described as the largest media industry transaction of the decade. Credit rating agencies have issued downgrades and reviews tied to the higher leverage expected once the transaction closes. U.S. telecom regulators have commented on the merger, underscoring...
NYSE:GSL
NYSE:GSLShipping

Global Ship Lease (GSL) Is Down 5.5% After Locking In US$2.24 Billion Contracted Revenue Backlog

Global Ship Lease, Inc. reported past fourth-quarter 2025 revenue of US$190.95 million and net income of US$102.61 million, with full-year 2025 revenue of US$766.45 million and net income of US$416.46 million, all higher than the prior year. Alongside these results, the company renewed and upgraded its fleet, locked in US$2.24 billion of contracted revenue with high charter coverage, reduced debt, and raised its dividend, increasing earnings visibility despite geopolitical uncertainty in key...
NYSE:OKE
NYSE:OKEOil and Gas

ONEOK (OKE) Is Up 5.0% After Dividend Hike And Debt Reduction Progress Has The Bull Case Changed?

In February 2026, ONEOK, Inc. reported past fourth-quarter and full-year 2025 results showing higher revenue and net income, issued 2026 earnings and volume guidance, and updated progress on its share repurchase program. The company paired these results with a 4% dividend increase, US$3.10 billions of long-term debt reduction, and sizable acquisition synergies, highlighting a focus on balance sheet strength and shareholder returns. We’ll now examine how ONEOK’s higher dividend and improved...
NYSE:AGRO
NYSE:AGROFood

Assessing Adecoagro (AGRO) Valuation After Recent Share Price Momentum

Recent performance snapshot Adecoagro (AGRO) has caught investor attention after a recent share price move, with the stock closing at US$10.16 and showing positive returns over the past week, month and past 3 months. Alongside this price action, the company reports annual revenue of US$1,386.018m and net income of US$23.403m. This provides a basic sense of its current scale and profitability before looking deeper into the business mix. See our latest analysis for Adecoagro. The recent 4.74% 1...